All Events

Understanding the genetic causes for variability in chromatin accessibility can shed light on the molecular mechanisms through which genetic variants may affect complex traits. Join us to hear Brandon Wenz from University of Pennsylvania share his latest research into chromatin accessibility quantitative trait loci (caQTLs) and their role in genetic regulation and complex traits. This study analyzed over 10,000 samples from 1,454 individuals across 600 studies, identifying 23,381 caQTLs. We'll discuss how joint genotyping, chromatin accessibility peak calling, and context-specific caQTL identification can reveal the genetic mechanisms that influence gene expression and contribute to disease, highlighting the potential of caQTL analyses in ungenotyped samples.

Thursday, October 3rd, 12:00 PM Eastern

Register here

Join Josh Setton from the Gencove team at the event, where he’ll be available to discuss how we’ve optimized every stage of data generation, both upstream and downstream. Learn how our modular, affordable, and scalable solutions are transforming genomic data generation, analysis, and management for biobanks and health systems. We’d love to connect with you—reach out to schedule a meeting!

Kansas City, get ready! David Neuman is headed your way to showcase how Gencove is revolutionizing genotyping. By leveraging cutting-edge sequencing technologies, we're making genomics more accessible and affordable, integrating it seamlessly into broader health and wellness services for comprehensive pet care. He'll be at:
Veterinary Innovation Summit, August 21-23, 2024
Fetch Kansas City, August 23-25, 2024
2024 Animal Health Summit, August 26-27, 2024

90% of therapeutic programs in clinical trials fail. Human genetic variation offers "natural experiments" that can inform successful therapeutic strategies with drug targets backed by human genetics 2-3 times more likely to succeed in the clinic. 23andMe has a dataset about ten times larger than current public cohorts, with approximately 15 million genotyped individuals, 80% of whom consent to research. In this session, you'll hear from Xin Wang, Ph.D., senior research scientist in statistical genetics at 23andMe as she explores how the scale of genetic data and improved methods to link genetic associations to causal genes impact clinical success predictions.

Dog research is at a crossroads. Like in humans, genetic tools could revolutionize veterinary care and improve the health and welfare of all dogs. However, widely used genetic testing services don’t provide researchers with the necessary information to achieve this vision. In this webinar, hear from Dr. Elinor Karlsson, who discusses a collaboration between Gencove, genomic scientists, and dog breeders. They have developed a new solution that combines high-accuracy genetic testing with comprehensive whole genome genotyping. This dual-purpose product supports breed ancestry analysis, Mendelian disease testing, and large-scale genomics.

The Gencove team will be at The Festival of Genomics & Biodata in Boston this year. Get in touch to meet us there and learn how Gencove is working with life sciences companies to accelerate R&D efforts across the drug development process

We're excited to be supporting the Beef Improvement Federation Research Symposium and Convention next week. Earlier this year we shared our vision for the future of the of the cattle industry and Joe Pickrell and David Neuman are looking forward to discussing with everyone in Knoxville.

The Gencove team will be at BIO in San Diego this year. Get in touch to meet us there and learn how Gencove is working with life sciences companies to accelerate R&D efforts across the drug development process

Gencove CEO & co-founder, Joe Pickrell is presenting at this years Bio-IT World Conference & Expo on Monday April 15th at 9:10am. Join us to hear how Gencove is working with life sciences companies to accelerate R&D efforts across the drug development process

We'll be at AGBT Ag in Phoenix this April. Get in touch to meet us there and learn more about Gencove's platform for genomic data generation, analysis and management.

Coupling rich electronic health record data with the ability to sequence patients of interest is key to the identification of molecular signatures of specific populations and their application to drug discovery. In our latest webinar, Olivia Sabik from Valo Health shares how their collaboration with Kahn-Sagol-Maccabi (KSM), Maccabi Healthcare Services' Research and Innovation Center, offers an unparalleled opportunity to identify patient cohorts using deep longitudinal data. She discusses how the unique population history of these cohorts provides an opportunity for groundbreaking discoveries and how Valo Health is leveraging the Gencove platform to accelerate this discovery.

We'll be at the World Agri-Tech Innovation Summit and Animal AgTech Innovation Summit in San Francisco this March. Get in touch to learn more about Gencove's platform for genomic data generation, analysis and management.